NO20041279L - Methylene-4-azasteroids. - Google Patents

Methylene-4-azasteroids.

Info

Publication number
NO20041279L
NO20041279L NONO/SPC/2A NO20041279A NO20041279L NO 20041279 L NO20041279 L NO 20041279L NO 20041279 A NO20041279 A NO 20041279A NO 20041279 L NO20041279 L NO 20041279L
Authority
NO
Norway
Prior art keywords
sup
methylene
denote
hydrogen atom
denotes
Prior art date
Application number
NONO/SPC/2A
Other languages
Norwegian (no)
Other versions
NO326564B1 (en
Inventor
Klaus Schollkopf
Walter Elger
Alexander Hillisch
Peter Droscher
Bernd Menzenbach
Hans-Udo Schweikert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20041279L publication Critical patent/NO20041279L/en
Publication of NO326564B1 publication Critical patent/NO326564B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

17-methylene-4-azasteroid compounds of formula I: wherein R<SUP>20 </SUP>denotes fluoro, chloro or bromo R<SUP>20a </SUP>denotes hydrogen, R<SUP>10 </SUP>and R<SUP>4 </SUP>each denote a hydrogen atom or a methyl group, and R<SUP>1 </SUP>and R<SUP>2 </SUP>each denote a hydrogen atom or together denote an additional bond, are useful for treating diseases or conditions caused by excessive androgen levels, such as acne, prostate diseases, alopecia and hirsutism, as well as gynecological conditions. Methods of synthesizing the new 17-methylene-4-azasteroid compounds are described.
NO20041279A 2001-08-28 2004-03-26 Methylene-4-azasteroids, processes for the preparation of the compounds, pharmaceutical compositions comprising them, and the use of the compounds for the preparation of pharmaceutical products NO326564B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141984A DE10141984A1 (en) 2001-08-28 2001-08-28 New 17-methylene-4-azasteroids
PCT/EP2002/009587 WO2003020744A1 (en) 2001-08-28 2002-08-28 Methylene-4-azasteroids

Publications (2)

Publication Number Publication Date
NO20041279L true NO20041279L (en) 2004-03-26
NO326564B1 NO326564B1 (en) 2009-01-12

Family

ID=7696782

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041279A NO326564B1 (en) 2001-08-28 2004-03-26 Methylene-4-azasteroids, processes for the preparation of the compounds, pharmaceutical compositions comprising them, and the use of the compounds for the preparation of pharmaceutical products

Country Status (22)

Country Link
US (1) US7186728B2 (en)
EP (1) EP1409513B1 (en)
JP (1) JP3927174B2 (en)
KR (1) KR100550514B1 (en)
CN (1) CN1322002C (en)
AT (1) ATE323100T1 (en)
AU (1) AU2002342625B8 (en)
BR (1) BR0212104A (en)
CA (1) CA2458932C (en)
CY (1) CY1105083T1 (en)
DE (2) DE10141984A1 (en)
DK (1) DK1409513T3 (en)
ES (1) ES2262856T3 (en)
HK (1) HK1071376A1 (en)
HU (1) HUP0401597A3 (en)
IL (2) IL160540A0 (en)
NO (1) NO326564B1 (en)
PL (1) PL367460A1 (en)
PT (1) PT1409513E (en)
RU (1) RU2293740C2 (en)
WO (1) WO2003020744A1 (en)
ZA (1) ZA200402368B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110628735B (en) * 2019-04-23 2022-04-08 天津科技大学 5 alpha-reductase mutant, genetically engineered bacterium and application of genetically engineered bacterium in efficient catalysis of 5 alpha-AD production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
ES2160842T3 (en) * 1995-10-23 2001-11-16 Merck & Co Inc DERIVATIVES OF STEROIDS 17-RENT-4-AZA-7-SUBSTITUTED.
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
EP1409512A1 (en) * 2000-06-27 2004-04-21 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase
DE10043846A1 (en) * 2000-09-04 2002-04-04 Jenapharm Gmbh 17-methylene steroids, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2002342625B8 (en) 2009-01-08
WO2003020744A1 (en) 2003-03-13
CA2458932A1 (en) 2003-03-13
US20040248921A1 (en) 2004-12-09
ATE323100T1 (en) 2006-04-15
AU2002342625B2 (en) 2008-12-04
NO326564B1 (en) 2009-01-12
IL160540A0 (en) 2004-07-25
PT1409513E (en) 2006-08-31
HUP0401597A3 (en) 2011-02-28
RU2004109166A (en) 2005-10-10
KR100550514B1 (en) 2006-02-13
HK1071376A1 (en) 2005-07-15
EP1409513B1 (en) 2006-04-12
ZA200402368B (en) 2005-05-20
HUP0401597A2 (en) 2004-12-28
CN1322002C (en) 2007-06-20
CN1549822A (en) 2004-11-24
JP2005504786A (en) 2005-02-17
US7186728B2 (en) 2007-03-06
RU2293740C2 (en) 2007-02-20
DK1409513T3 (en) 2006-08-14
BR0212104A (en) 2004-08-24
CA2458932C (en) 2008-07-22
IL160540A (en) 2009-11-18
PL367460A1 (en) 2005-02-21
KR20040032978A (en) 2004-04-17
JP3927174B2 (en) 2007-06-06
DE50206397D1 (en) 2006-05-24
EP1409513A1 (en) 2004-04-21
ES2262856T3 (en) 2006-12-01
DE10141984A1 (en) 2003-03-20
CY1105083T1 (en) 2009-11-04

Similar Documents

Publication Publication Date Title
ATE469892T1 (en) SUBSTITUTED 1H-DIHYDROPYRAZOLES, THEIR PREPARATION AND USE
MXPA03011006A (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds.
ATE253545T1 (en) BIARYLACETIC ACID DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS
MXPA04001323A (en) Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates their preparation and use.
BRPI0413305A (en) fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 receptor (vr1)
BR0114045A (en) Polyarylcarboxamides useful as lipid lowering agents
ATE357434T1 (en) DISUBSTITUTED THIAZOLYLCARBOXANILIDES AND THEIR USE AS MICROBICIDES
MXPA02011370A (en) Substituted iminoazines.
EA200300836A1 (en) DERIVATIVES OF PHTHALASINON-PIPERIDINE AS PDE4 INHIBITORS
WO2001017963A3 (en) Aminoalkoxy carbazoles and their use as 5-ht ligands
MY141853A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
DE602004009200D1 (en) TETRAHYDROCHINAZOLINE DERIVATIVES AS CFR ANTAGONISTS
DE50002836D1 (en) SUBSTITUTED ANILINE COMPOUNDS
DE50208918D1 (en) 6-AMINOMORPHINANDERIVATE, METHOD OF MANUFACTURING THEREFOR AND THEIR USE
TR200302288T2 (en) New compounds and methods for therapy.
EA200100040A1 (en) CHEMICAL SYNTHESIS OF MORFOLINE DERIVATIVES
ATE353884T1 (en) MULTIFUNCTIONAL CATIONIC PHOTOINITIATORS, THEIR PRODUCTION AND USE
PT1204659E (en) SEROTONINERGIC BENZOFURANOS
EA200200727A1 (en) NEW INDOL DERIVATIVES
ATE323100T1 (en) METHYLENE-4-AZASTEROIDS
ATE502030T1 (en) IMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
EA200500032A1 (en) DERIVATIVES OF ACYLOXYPYRROLIDINE AND THEIR APPLICATION AS V1B OR V1B AND V1A RECEPTORS LIGANDS
NO20033049D0 (en) Process for the preparation of (+/-) trans-4-p-fluorophenyl-3-hydroxymethyl-1
ATE319708T1 (en) AZOLE OR TRIAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES
DE59907215D1 (en) SUBSTITUTED BENZIMIDAZOLES, THEIR PRODUCTION AND THEIR USE AS A MEDICINE AGAINST PARASITAL PROTOZOES

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees